Interestingly, our identified genetic variants in sulfate metabolism genes (SUOX), which may regulate oxidative stress pathways – a known target of SGLT2 inhibitors – might offer new perspectives on CI in DKD patients. Here, SLC5A2 is linked to diabetic kidney disease.